Authors
This report is concerned with the presence of an inhibitor of antihemophiliac globulin (AHG, VIII) in a patient with multiple myeloma. Al- though inhibitors against AHG have been de- scribed in a variety of disorders (1-4), to our knowledge they have not been described in mye- loma.
No takes yet. Share an insight, caveat, or question.
Glueck et al. (1965) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: